22.07.2016 • News

Air Products Building Gases Plant in China

US industrial gases producer Air Products is building a new plant for ultra-high purity gases and related infrastructure in the Pukou Economic Development Zone (PKEDZ) near Nanjing in eastern China. The site is 35 kilometers from the Nanjing Chemical Industry Park (NCIP), where the US gases producer has already built up a position serving several hundred customers through pipelines and other supply modes.

Output at PKEDZ is earmarked for Air Products customers in the chemical park that will be home to advanced manufacturing sectors including integrated circuit (IC), new materials and biomedicine.

“This is a strategic project and important milestone for Air Products. First, it demonstrates our commitment to support our valued customers as they expand internationally,” said Saw Choon Seong, China president, Industrial Gases, Air Products.

Second, Saw said, the investment positions the company for continued growth, fueled by China’s booming semiconductor industry and its high-tech manufacturing target under the 13th Five Year Plan. It is also designed further strengthen the gases producer’s position in Nanjing, which he said “is a rising star of world-class IC manufacturing.”

In the NCIP park, where Air Products began investing 10 years ago, the company operates three large air separation units serving multiple park tonnage customers, including Wison and Celanese, via pipelines as well the city’s merchant gas markets.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

most read